Skip to content

Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)

Effects of tDCS in Cortical Plasticity and Motor Learning in Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01852474
Enrollment
5
Registered
2013-05-13
Start date
2013-05-31
Completion date
2016-05-31
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

motor learning, cortical plasticity, direct current stimulation

Brief summary

In this study, the investigators aim to assess the clinical and neurophysiological effects of a non-invasive brain stimulation technique - transcranial direct current stimulation (tDCS)- on cortical plasticity and motor learning in children with cerebral palsy. Investigators will use different assessment techniques, such as transcranial magnetic stimulation (TMS) and kinematics (sensors) to measure changes through the trial.

Interventions

DEVICETranscranial Direct Current Stimulation (tDCS)

Subjects will receive tDCS stimulation 1x per day for 5 days (over the period of 1 week). Each session will be 20 minutes long. The subject will receive active stimulation for the entire 20 minutes.

Sponsors

Pedal with Pete
CollaboratorUNKNOWN
Spaulding Rehabilitation Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age of participants must be between 8 and 18 years old. * Diagnosis of spastic or mixed CP with distribution of diplegia and/or hemiplegia form. * Gross Motor Function Classification System for Cerebral Palsy (GMFCS) level II and III. * Manual Ability Classification System for Children with CP (MACS) level II up to IV. * Ability to cooperate and follow directions.

Exclusion criteria

* Muscle tone reduction therapy in the past 3 months prior to study onset. * Upper limb orthopedic surgery in the past 3 months prior to study onset. * Any other form of therapy or procedure involving motor neuron junction inhibition; either by biochemical and/or mechanical denervation, in the past 3 months prior to study onset. * History of convulsive disorder in the past 2 years prior to study onset. * Current use of carbamazepine as anticonvulsive therapy. * Presence ventriculoperitoneal shunt.

Design outcomes

Primary

MeasureTime frameDescription
Changes in motor assessmentsApproximately 2 weeksInvestigators will measure changes in kinematic (sensor) assessments from baseline to follow-up. The sensor will collect Inertial Measurements Units (IMU) and complex motion sensing, as measured by accelerometer/gyroscope/magnetometer of freedom motion capture.

Secondary

MeasureTime frameDescription
Changes in TMS measurementsApproximately 2 weeksInvestigators will measure change in TMS measurements from baseline to follow-up. TMS measures will consist of: motor threshold, motor evoked potentials (MEP's), transcallosal inhibition, and examinations of intracortical inhibition and facilitation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026